ViiV Healthcare

ViiV Healthcare HIV treatment shows success in 2-month treatment trial

Posted by WRAL TechWire | Aug 22, 2019

“Approval of this regimen would mark a significant change in the HIV treatment paradigm,” says the head of R&D at ViiV Healthcare.

Chief medical officer at HIV-focused ViiV Healthcare is stepping down

Posted by WRAL TechWire | Jul 19, 2019

The longtime chief science and medical officer at ViiV Healthcare, which has a major presence, is stepping down in the near future.

Headlines: Fortnite World Cup; blocking robo calls; Alexa & your health; ViiV’s good data; Microsoft vs. Slack; Apple kills 2 Macs

Posted by WRAL TechWire | Jul 10, 2019

Tech headlines impacting the Triangle ecosystem include news about Fortnite World Cup, robo call blocking, Alexa as health tool, ViiV’s good data, Microsoft vs. Slack, and Apple kills 2 Macs. Check out the links.

ViiV Healthcare’s HIV drug OK’d for European sales

Posted by WRAL News | Jul 5, 2019

Dovato is a combination of the drugs dolutegravir and lamivudine. It was approved in Europe for treating adults and adolescents over 12 years old who are living with HIV.

ViiV Healthcare seeks FDA approval for long-term injectable HIV treatment

Posted by WRAL TechWire | Apr 29, 2019

ViiV Healthcare, which operates a major research and development operation in RTP, is seeking FDA approval for what it says would be the first long-term injectable HIV treatment that contains two drugs.

Results of monthly shots to combat AIDS in trials boosts ViiV Healthcare’s combo treatment

Posted by WRAL TechWire | Mar 8, 2019

Monthly shots of HIV drugs worked as well as daily pills to control the virus that causes AIDS in two large international tests, researchers reported Thursday. That’s good news for ViiV Healthcare, which has a large operation in RTP.

Headlines: Good ViiV news; Apple jobs in San Diego; AT&T spectrum buys; Bezos, Microsoft back fusion; Alexa music update; new Fitbit devices

Posted by WRAL TechWire | Mar 7, 2019

Our latest roundup of technology headlines includes: Apple adding jobs in San Diego, AT&T buying spectrum – is it for 5g?; Jeff Bezos and Microsoft invest in fusion energy, and more.

GSK’s ViiV Healthcare reports ‘landmark’ results for drug to control HIV

Posted by WRAL TechWire | Jun 14, 2018

ViiV Healthcare, which has researchers based in RTP, is reporting what it calls “landmark” late-stage clinical trial results for its two-drug combo that it says is “demonstrating the ability to control HIV.”